Aspen Aerogels INC 8-K filings

Aspen Aerogels announced Q2 2026 financial results showing a significant year-over-year revenue decrease, impacted by an East Providence incident, but projects a strong Q3 rebound.

Aspen Aerogels announced the staged restart of its East Providence facility following an incident review and appointed its CFO as principal accounting officer.

Aspen Aerogels announced first quarter 2026 financial results, reporting $37.9 million in revenue and a net loss of $23.7 million, while detailing plans for a staged restart of its East Providence facility.

Aspen Aerogels reports that its East Providence manufacturing facility remains offline following an April 8, 2026, explosion.

Aspen Aerogels reported a significant net loss and revenue decline for Q4 and full year 2025, driven by reduced EV demand, and announced a strategic review to optimize its competitive position.

Aspen Aerogels, a leader in sustainability and electrification solutions, announced an amendment to its MidCap credit facility, updating financial covenants for greater flexibility.

Aspen Aerogels reports a Q3 2025 net loss of $6.3 million and significantly lowers its full-year outlook due to challenging U.S. EV demand and a large impairment charge.

Aspen Aerogels, Inc. announced the promotion of Grant Thoele to Chief Financial Officer and Treasurer, effective October 1, 2025, succeeding Ricardo C. Rodriguez.

Aspen Aerogels, Inc. announced a net loss of $9.1 million for Q2 2025, impacted by significant restructuring and impairment charges, while projecting improved Adjusted EBITDA for the second half of the year.

Aspen Aerogels announced its Q1 2025 financial results, including a significant net loss due to an impairment charge, but highlighted a new PyroThin contract with a leading American OEM.

Aspen Aerogels' stockholders approved an amended equity incentive plan and an employee stock purchase plan at the 2025 Annual Meeting.

Aspen Aerogels has granted performance share units (PSUs) to its executive officers as part of its 2025 long-term incentive program, linking rewards to the company's total stockholder return relative to the Russell 2000 Index.

Aspen Aerogels reveals the upcoming retirement of two board members and subsequent adjustments to board committee leadership following the 2025 Annual Meeting of Stockholders.

Aspen Aerogels announces a 90% year-over-year increase in FY 2024 revenue, reaching $452.7 million, driven by growth in both Thermal Barrier and Energy Industrial segments.

Aspen Aerogels has amended and restated its Code of Business Conduct and Ethics, effective November 14, 2024, as part of its regular policy review.

Aspen Aerogels announced a significant increase in revenue and profitability for the third quarter of 2024, driven by strong performance in its Thermal Barrier business and improved operational efficiency.

Aspen Aerogels has priced a public offering of 4,250,000 shares of its common stock at $20.00 per share, expecting to raise approximately $85 million before expenses.

Aspen Aerogels has received a conditional commitment for a $670.6 million loan from the Department of Energy to fund its second aerogel manufacturing facility, while also reporting preliminary Q3 2024 revenue of $117 million and adjusted EBITDA of $25 million.

Aspen Aerogels has amended and restated its executive employment agreement with CEO Donald R. Young, extending his term through August 30, 2027, with potential for automatic one-year renewals.

Aspen Aerogels has finalized a $125 million term loan and a $100 million revolving credit facility with MidCap Financial, using the proceeds to redeem its existing convertible notes and for general corporate purposes.

Aspen Aerogels has appointed Cari Robinson to its Board of Directors, effective August 14, 2024, adding her extensive experience in legal, risk, and governance to the company.

Aspen Aerogels announced record second-quarter revenue of $117.8 million, a 145% year-over-year increase, and raised its full-year 2024 financial outlook.

Aspen Aerogels has announced a new thermal barrier design award from Valmet Automotive for the electric Porsche 718 series and has reaffirmed its financial outlook for 2024.

Aspen Aerogels successfully held its 2024 annual meeting, electing two Class I directors, ratifying KPMG as its auditor, and approving executive compensation in a non-binding vote.

Aspen Aerogels announced a significant increase in revenue and profitability for Q1 2024, leading to an improved full-year outlook.

Aspen Aerogels has cancelled unvested performance-based restricted shares for several employees, resulting in a $2.2 million charge.

Aspen Aerogels announced strong fourth-quarter and full-year 2023 results, highlighted by record revenue, improved gross margins, and a positive outlook for 2024.

Aspen Aerogels reports preliminary full-year 2023 revenue of $238 million, a 32% increase year-over-year, and anticipates over 47% revenue growth in 2024.